CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 886 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01418313
NCT01418313N/ACompleted
CompareCT.gov

In Vivo Molecular Imaging (MRI) of Atherothrombotic Lesions

Icahn School of Medicine at Mount Sinai·observational·Posted Aug 17, 2011·Updated Aug 3, 2020

In Brief

An observational study for Atherosclerosis. Completed, enrolled 886 participants across 1 site.

Detailed Summary

The purpose of this study is to develop and validate novel magnetic resonance imaging (MRI), dynamic contrast enhanced (DCE)-MRI and positron emission tomography (PET)/MR techniques for the detection and risk stratification of patients with atherosclerosis.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtherosclerosis
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), NYU Langone Health

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 17, 2011
Enrollment StartSep 1, 2011
Primary CompletionMar 9, 2020
TodayJul 2, 2026
Enrollment to primary: 8.5 yearsPosted 14.9 years ago